Neuroprotective Effects of INT-777 Against Aβ1–42-induced Cognitive Impairment, Neuroinflammation, Apoptosis, and Synaptic Dysfunction in Mice

Xian Wu,Yang-Ge Lv,Yi-Feng Du,Fang Chen,Miranda N. Reed,Mei Hu,Vishnu Suppiramaniam,Su-Su Tang,Hao Hong

DOI: https://doi.org/10.1016/j.bbi.2018.06.018

IF: 19.227

2018-01-01

Brain Behavior and Immunity

Abstract:Increasing evidence demonstrates that the neurotoxicity of amyloid-beta (A beta) deposition plays a causative role in Alzheimer's disease (AD). Herein, we evaluated the neuroprotective effects of 6 alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777), a specific G-protein coupled bile acid receptor 1 (TGR5) agonist, in the A beta(1-42)-treated mouse model of acute neurotoxicity. Single intracerebroventricular (i.c.v.) injection of aggregated A beta(1-42) (410 pmol/mouse; 5 mu l) into the mouse brain induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction. In contrast, INT-777 (1.5 or 3.0 mu g/mouse, i.c.v.) significantly improved A beta(1-42)-induced cognitive impairment, as reflected by better performance in memory tests. Importantly, INT-777 treatment reversed A beta(1-42)-induced TGR5 down-regulation, suppressed the increase of nuclear NF-kappa B p65, and mitigated neuroinflammation, as evidenced by lower proinflammatory cytokines and less Iba1-positive cells in the hippocampus and frontal cortex. INT-777 treatment also pronouncedly suppressed apoptosis through the reduction of TUNEL-positive cells, decreased caspase-3 activation, increased the ratio of Bcl-2/Bax, and ameliorated synaptic dysfunction by promoting dendritic spine generation with the upregulation of postsynaptic and pre-synaptic proteins (PSD95 and synaptophysin) in A beta(1-42)-treated mice. Our results indicate that INT-777 has potent neuroprotective effects against A beta(1-42)-induced neurotoxicity. Taken together, these findings suggest that the activation of TGR5 could be a novel and promising strategy for the treatment of AD.